GYRE Shares Outstanding History Table | ||||||||
Also see: GYRE Market Cap History GYRE YTD Return |
GYRE Shares Outstanding History Table | ||||||||
Also see: GYRE Market Cap History GYRE YTD Return |
GYRE Shares Outstanding History Chart | |||||||||
+183.12% CAGR Mouse over chart for data details
|
GYRE Stock Price Chart |
About Gyre Therapeutics Inc |
Catalyst Biosciences, together with its subsidiary, is a biopharmaceutical company focused on the development and commercialization of Hydronidone for the treatment of NASH (nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease) in the U.S. Hydronidone is being evaluated for the treatment of liver fibrosis associated with a spectrum of chronic liver diseases. A Phase 1 clinical trial of Hydronidone has been completed in the U.S. and generated pharmacokinetic, safety and tolerability data of single and multiple ascending doses of Hydronidone in U.S. healthy subjects. We show 3 historical shares outstanding datapoints in our coverage of GYRE's shares outstanding history. Understanding the changing numbers of GYRE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GYRE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GYRE by allowing them to research GYRE shares outstanding history as well as any other stock in our coverage universe. |
GYRE Current Stock Quote |
Free GYRE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
GYRE Share Performance |
Shares Outstanding Peers |
Gyre Therapeutics (GYRE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
HAE Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.